Pulmatrix(美國(guó))

Pulmatrix

美國(guó)Pulmatrixwww.pulmatrix.comPulmatrix公司，一個(gè)臨床階段的生物制藥公司，開發(fā)用于治療，預(yù)防和傳輸控制的傳染病和進(jìn)步呼吸系統(tǒng)疾病的吸入療法。它提供吸入呼吸道襯調(diào)制陽(yáng)離子藥物，刺激呼吸道內(nèi)的宿主防御機(jī)制來治療和預(yù)防流感，鼻病毒，慢性肺疾病。該公司成立于2003年，總部設(shè)在美國(guó)馬薩諸塞州列克星敦。Pulmatrixisaclinicalstagebiotechnolo gycompanywithaninhaleddrypowderplatformadvancinganewgenerationofinhaledtherapeutics.Theplatform,callediSPERSE(inhaledsmallparticleseasilyrespirableanddispersible),representsanewparadigmininhaleddrugdeliverybasedonuniqueproperties:dense,highdrugloadengineeredparticleswithhighlyefficientdispersibilityanddeliverytotheairways.TheiSPERSEpowderscanbeusedwithanarrayofdrypowderinhalertechnologiesandcanbeformulatedwithvirtuallyanydrugsubstanceincludingournoveliCALM(inhaledCationicAirwayLiningModulators)therapies,smallmolecules,biologics,andmulti-drugcombinations.WiththeiSPERSEplatform,Pulmatrixisdevelopingabroadpipelinetopreventandtreatarangeofrespir